19:50 EDT Kazia Therapeutics (KZIA) trading halted, news pending
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KZIA:
- Kazia Therapeutics Announces ADS Ratio Change to Maintain Nasdaq Compliance
- Kazia Therapeutics Sells Cantrixil IP Rights to Vivesto for $1 Million
- Kazia Therapeutics sells IP, trademarks rights to Cantrixil for $1M
- Kazia Therapeutics Advances Cancer Drug Development with Strategic Moves and Promising Trial Results
- Kazia Therapeutics: Buy Rating Driven by Dual Potential in GBM and Parkinson’s Disease